And studies have found that in mice bearing TC1 murine prostate tumors, whether they were treated with antiandrogen therapy or silencing of AR, the expression of IL-6 and STAT3 in mouse tumors would increase. This evidence concerns the gene STAT3 and prostate neoplasm.